SETH WAGNER: Open Payments
NPI 1659506277 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$539 in 28 payments from 12 companies in 2025. Trend: 2023 $677 · 2024 $640 · 2025 $539
Food & beverage: $539
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $139 |
| Astellas Pharma US Inc | 3 | $71 |
| PFIZER INC. | 3 | $67 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Lilly USA, LLC | 3 | $48 |
| Dexcom, Inc. | 2 | $31 |
| Axsome Therapeutics, Inc. | 2 | $31 |
| ABBVIE INC. | 1 | $28 |
| Abbott Laboratories | 1 | $20 |
| Corcept Therapeutics | 1 | $18 |
Products named: Ozempic, Veozah, ELIQUIS, Wegovy, FARXIGA, MOUNJARO, Dexcom G6 Transmitter, Auvelity.
Industry payments across GA — which companies pay providers there.
